Prime Medicine, One Year Return vs. Price To Earning
| PRME Etf | USD 3.16 0.06 1.86% |
For Prime Medicine, profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Prime Medicine, to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Prime Medicine, Common utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Prime Medicine,'s most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Prime Medicine, Common over time as well as its relative position and ranking within its peers.
Prime |
The market value of Prime Medicine, Common is measured differently than its book value, which is the value of Prime that is recorded on the company's balance sheet. Investors also form their own opinion of Prime Medicine,'s value that differs from its market value or its book value, called intrinsic value, which is Prime Medicine,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prime Medicine,'s market value can be influenced by many factors that don't directly affect Prime Medicine,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prime Medicine,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Prime Medicine, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prime Medicine,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Prime Medicine, Common Price To Earning vs. One Year Return Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Prime Medicine,'s current stock value. Our valuation model uses many indicators to compare Prime Medicine, value to that of its competitors to determine the firm's financial worth. Prime Medicine, Common is regarded third largest ETF in one year return as compared to similar ETFs. It is rated below average in price to earning as compared to similar ETFs . Comparative valuation analysis is a catch-all technique that is used if you cannot value Prime Medicine, by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Prime Price To Earning vs. One Year Return
One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
Prime Medicine, |
| = | (0.31) % |
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Prime Medicine, |
| = | 14.40 X |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Prime Price To Earning Comparison
Prime Medicine, is currently under evaluation in price to earning as compared to similar ETFs.
Prime Medicine, Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Prime Medicine,, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Prime Medicine, will eventually generate negative long term returns. The profitability progress is the general direction of Prime Medicine,'s change in net profit over the period of time. It can combine multiple indicators of Prime Medicine,, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. Prime Medicine is listed under Biotechnology in the United States and is traded on NASDAQ Exchange exchange.
Prime Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Prime Medicine,. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Prime Medicine, position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Prime Medicine,'s important profitability drivers and their relationship over time.
| One Year Return vs Price To Book | ||
| Price To Sales vs Price To Earning | ||
| One Year Return vs Beta | ||
| Three Year Return vs Price To Earning | ||
| One Year Return vs Net Asset | ||
| Equity Positions Weight vs Price To Earning |
Use Prime Medicine, in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Prime Medicine, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prime Medicine, will appreciate offsetting losses from the drop in the long position's value.Prime Medicine, Pair Trading
Prime Medicine, Common Pair Trading Analysis
The ability to find closely correlated positions to Prime Medicine, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Prime Medicine, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Prime Medicine, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Prime Medicine, Common to buy it.
The correlation of Prime Medicine, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Prime Medicine, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Prime Medicine, Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Prime Medicine, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Prime Medicine, position
In addition to having Prime Medicine, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Tips ETFs Thematic Idea Now
Tips ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Tips ETFs theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tips ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Prime Etf
To fully project Prime Medicine,'s future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Prime Medicine, Common at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Prime Medicine,'s income statement, its balance sheet, and the statement of cash flows.